| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 138 |
| 1 | METHOTREXATE SODIUM | 136 |
| 2 | METHOTREXATE | 129 |
| 3 | LEFLUNOMIDE | 120 |
| 4 | TOCILIZUMAB | 112 |
| 5 | ABATACEPT | 108 |
| 6 | INFLIXIMAB | 108 |
| 7 | RITUXIMAB | 108 |
| 8 | ETANERCEPT | 104 |
| 9 | ANAKINRA | 96 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 86 | 0.0148 |
| 1 | ANAKINRA | 96 | 0.0057 |
| 2 | CORTISONE ACETATE | 56 | 0.0045 |
| 3 | DESOXIMETASONE | 56 | 0.0029 |
| 4 | PAMABROM | 1 | 0.0027 |
| 5 | RISEDRONATE SODIUM | 71 | 0.0023 |
| 6 | HUMAN IMMUNOGLOBULIN G | 45 | 0.0021 |
| 7 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 49 | 0.0020 |
| 8 | CALCIUM GLUCONATE | 22 | 0.0018 |
| 9 | TRICLOSAN | 1 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 96 | 0.0057 |
| 1 | Human Immunoglobulin G [EPC] | 45 | 0.0021 |
| 2 | Antirheumatic Agent [EPC] | 120 | 0.0011 |
| 3 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 113 | 0.0008 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 108 | 0.0008 |
| 6 | Aminosalicylate [EPC] | 75 | 0.0007 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 108 | 0.0003 |
| 9 | Calcitonin [EPC] | 1 | 0.0003 |